New Delhi: The Union government has finalised arrangements with Hyderabad-based vaccine manufacturer, Biological-E, to reserve 300 million Covid-19 vaccine doses, Union Ministry of Health and Family Welfare said today.
The doses will be manufactured and stockpiled by Biological-E from August to December 2021, said the Ministry.
Biological-E’s vaccine is currently in Phase-3 clinical trials after showing promising results in Phase 1 and 2, said the government in a statement.
The vaccine is likely to be available in the next few months, according to the statement.
Besides Covaxin and Serum Institute of India’s Covishield, Russia’s Sputnik V will soon be used to vaccinate people as the government races to a target of one crore vaccinations a day by August. It is also in talks with foreign makers like Pfizer and Moderna, who have insisted on an indemnity clause.
“The arrangement with M/s Biological-E is part of the wider endeavour of Government of India to encourage indigenous vaccine manufacturers by providing them support in Research & Development (R&D) and also financial support,” the statement read.